Literature DB >> 6273554

The effect of calcium and magnesium ions on calcium pyrophosphate crystal formation in aqueous solutions.

P T Cheng, K P Pritzker.   

Abstract

Calcium pyrophosphate crystal formation has been associated clinically with hypercalcemic states (hyperparathyroidism) and hypomagnesemia. We studied aqueous solutions at pH 7.4, 37 degrees C, [Na+] = 140 nM over a range of calcium chloride/magnesium chloride/sodium pyrophosphate concentrations to determine the effect of calcium and magnesium ions on crystal formation. We found that CPPD(T) and CPPD(M) could form under different ionic conditions. Low [Mg++] and [PPi] favoured CPPD(T) whereas higher [Mg++] and [PPi] favoured CPPD(M). At [Mg++] = 1.0 mM a calcium magnesium pyrophosphate crystal phase designated CMPP2 formed. As [Mg++] affects the crystal phase formed more than equimolar [Ca++], we conclude that ionic magnesium deficiency may be a clinically important determinant in calcium pyrophosphate dihydrate crystal formation.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6273554

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  9 in total

1.  Effect of glycosaminoglycans on calcium pyrophosphate crystal formation in collagen gels.

Authors:  G K Hunter; M D Grynpas; P T Cheng; K P Pritzker
Journal:  Calcif Tissue Int       Date:  1987-09       Impact factor: 4.333

2.  Synthesis of triclinic calcium pyrophosphate crystals.

Authors:  P J Groves; R M Wilson; P A Dieppe; R P Shellis
Journal:  J Mater Sci Mater Med       Date:  2007-02-03       Impact factor: 3.896

3.  Interleukin-1 induces pro-mineralizing activity of cartilage tissue transglutaminase and factor XIIIa.

Authors:  K Johnson; S Hashimoto; M Lotz; K Pritzker; R Terkeltaub
Journal:  Am J Pathol       Date:  2001-07       Impact factor: 4.307

4.  Proceedings of a symposium on crystal-related arthropathies. 22 October and 23 October, 1982, Bristol Polytechnic, Bristol.

Authors: 
Journal:  Ann Rheum Dis       Date:  1983-08       Impact factor: 19.103

5.  Solution Ca/P ratio affects calcium phosphate crystal phases.

Authors:  P T Cheng; K P Pritzker
Journal:  Calcif Tissue Int       Date:  1983-07       Impact factor: 4.333

6.  Identification of monoclinic calcium pyrophosphate dihydrate and hydroxyapatite in human sclera using Raman microspectroscopy.

Authors:  Ko-Hua Chen; Mei-Jane Li; Wen-Ting Cheng; Tonci Balic-Zunic; Shan-Yang Lin
Journal:  Int J Exp Pathol       Date:  2009-02       Impact factor: 1.925

7.  Octacalcium phosphate formation in vitro: implications for bone formation.

Authors:  P T Cheng
Journal:  Calcif Tissue Int       Date:  1985-01       Impact factor: 4.333

8.  Inhibition of calcium pyrophosphate dihydrate crystal formation: effects of carboxylate ions.

Authors:  P T Cheng; K P Pritzker
Journal:  Calcif Tissue Int       Date:  1988-01       Impact factor: 4.333

Review 9.  Calcium pyrophosphate crystal deposition disease: diagnosis and treatment.

Authors:  José Luis Rosales-Alexander; Jerónimo Balsalobre Aznar; César Magro-Checa
Journal:  Open Access Rheumatol       Date:  2014-05-08
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.